Literature DB >> 14707133

Involvement of glycosylphosphatidylinositol-linked ceruloplasmin in the copper/zinc-nitric oxide-dependent degradation of glypican-1 heparan sulfate in rat C6 glioma cells.

Katrin Mani1, Fang Cheng, Birgitta Havsmark, Samuel David, Lars-Ake Fransson.   

Abstract

The core protein of glypican-1, a glycosylphosphatidylinositol-linked heparan sulfate proteoglycan, can bind Cu(II) or Zn(II) ions and undergo S-nitrosylation in the presence of nitric oxide. Cu(II)-to-Cu(I)-reduction supports extensive and permanent nitrosothiol formation, whereas Zn(II) ions appear to support a more limited, possibly transient one. Ascorbate induces release of nitric oxide, which catalyzes deaminative degradation of the heparan sulfate chains on the same core protein. Although free Zn(II) ions support a more limited degradation, Cu(II) ions support a more extensive self-pruning process. Here, we have investigated processing of glypican-1 in rat C6 glioma cells and the possible participation of the copper-containing glycosylphosphatidylinositol-linked splice variant of ceruloplasmin in nitrosothiol formation. Confocal microscopy demonstrated colocalization of glypican-1 and ceruloplasmin in endosomal compartments. Ascorbate induced extensive, Zn(II)-supported heparan sulfate degradation, which could be demonstrated using a specific zinc probe. RNA interference silencing of ceruloplasmin expression reduced the extent of Zn(II)-supported degradation. In cell-free experiments, the presence of free Zn(II) ions prevented free Cu(II) ion from binding to glypican-1 and precluded extensive heparan sulfate autodegradation. However, in the presence of Cu(II)-loaded ceruloplasmin, heparan sulfate in Zn(II)-loaded glypican-1 underwent extensive, ascorbate-induced degradation. We propose that the Cu(II)-to-Cu(I)-reduction that is required for S-nitrosylation of glypican-1 can take place on ceruloplasmin and thereby ensure extensive glypican-1 processing in the presence of free Zn(II) ions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707133     DOI: 10.1074/jbc.M313678200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease.

Authors:  Puneet Anand; Jonathan S Stamler
Journal:  J Mol Med (Berl)       Date:  2012-02-24       Impact factor: 4.599

2.  Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation.

Authors:  Fang Cheng; Roberto Cappai; Giuseppe D Ciccotosto; Gabriel Svensson; Gerd Multhaup; Lars-Åke Fransson; Katrin Mani
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

3.  S-nitrosylation in the regulation of gene transcription.

Authors:  Yonggang Sha; Harvey E Marshall
Journal:  Biochim Biophys Acta       Date:  2011-05-24

4.  Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation.

Authors:  Michael T Forrester; Divya Seth; Alfred Hausladen; Christine E Eyler; Matthew W Foster; Akio Matsumoto; Moran Benhar; Harvey E Marshall; Jonathan S Stamler
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

5.  Reversible S-nitrosylation in an engineered azurin.

Authors:  Shiliang Tian; Jing Liu; Ryan E Cowley; Parisa Hosseinzadeh; Nicholas M Marshall; Yang Yu; Howard Robinson; Mark J Nilges; Ninian J Blackburn; Edward I Solomon; Yi Lu
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

Review 6.  Glutathione in Protein Redox Modulation through S-Glutathionylation and S-Nitrosylation.

Authors:  Elena Kalinina; Maria Novichkova
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

Review 7.  Pillars and Gaps of S-Nitrosylation-Dependent Epigenetic Regulation in Physiology and Cancer.

Authors:  Luisa Salvatori; Francesco Spallotta; Carlo Gaetano; Barbara Illi
Journal:  Life (Basel)       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.